Eriksson, Kjell published the artcileMAb contaminant removal with a multimodal anion exchanger: a platform step to follow protein A, Computed Properties of 101-98-4, the publication is BioProcess International (2009), 7(2), 52-57, database is CAplus.
Monoclonal antibodies (MAbs) constitute approx. 30% of the biopharmaceutical products currently under development. Today, nearly all approved MAb processes include a capture step using protein A. GE Healthcare’s Capto adhere multimodal anion-exchange resin, which has high selectivity for contaminants that remain after protein A separation, represents an addnl. step toward developing highly effective MAb downstream processes. The high purity that follows capture on protein A resins, combined with the multimodal functionality of Capto adhere resin, provides for highly productive, two-step processes.
BioProcess International published new progress about 101-98-4. 101-98-4 belongs to alcohols-buliding-blocks, auxiliary class Amine,Benzene,Alcohol, name is 2-(Benzyl(methyl)amino)ethanol, and the molecular formula is C10H15NO, Computed Properties of 101-98-4.
Referemce:
https://en.wikipedia.org/wiki/Alcohol,
Alcohols – Chemistry LibreTexts